Tower Research Capital (TRC)’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
Other funds holding LEXX
Tower Research Capital (TRC)'s LEXX Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Lexaria Bioscience (LEXX) stake by 17,680% in Q3 2026, buying an estimated $13.4K and bringing the position to 1,778 shares worth $5.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4599.
Tower Research Capital (TRC) first reported a position in LEXX in Q2 2021 and has held it in 19 quarters since. The position peaked at $12K in Q4 2022. 15 funds tracked by Wall St. Rank hold LEXX as of Q3 2026.
- Tower Research Capital (TRC) held 1,778 shares of Lexaria Bioscience worth $5.6K as of Q3 2026.
- Tower Research Capital (TRC) bought 1,768 Lexaria Bioscience shares in Q3 2026, an estimated $13.4K.
- Lexaria Bioscience made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4599 holding.
- Tower Research Capital (TRC) first reported a position in Lexaria Bioscience in Q2 2021 and has held it in 19 quarters since.
- Tower Research Capital (TRC)'s Lexaria Bioscience position peaked at $12K in Q4 2022.
- 15 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.